Aberrant p63 and WT-1 expression in myoepithelial cells of pregnancy-associated breast cancer: Implications for tumor aggressiveness and invasiveness

International Journal of Biological Sciences

Volumn 5, Issue 1, 2009, Pages 82-96

  Xu, Zheli ^a   Wang, Wan ^a   Deng, Chu Xia ^b   Man, Yan Gao ^c  

^a JILIN UNIVERSITY   (China)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

Myoepithelial cells; p63; Pregnancy associated breast cancer; Tumor stem cells; WT 1

Indexed keywords

CALPONIN; ESTROGEN RECEPTOR; MASPIN; PROGESTERONE RECEPTOR; PROTEIN P63; TUMOR SUPPRESSOR PROTEIN; WT1 PROTEIN;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER GRADING; CANCER INVASION; CANCER MORTALITY; CANCER STAGING; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MYOEPITHELIUM CELL; PREGNANCY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TISSUE SECTION;

EID: 60049086605     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.5.82     Document Type: Article

References (53)

1. Guelstein VI, Tehypysheva TA, Ermilova VD, Liubimov AV. Myoepithelial and besement membrane antigens in benign and malignant human breast tumors. In J Cancer. 1993; 53:269-77.
2. Miosge N. The ultrastructural composition of basement membrane in vivo. Histol Histopathol 2001; 16:1239-48
3. Jolicoeur F, Seemayer TA, Gabbiani G. Multifocal, nascent, and invasive myoepithelial carcinoma (malignant myoepithelioma) of the breast: an immunohistochemical and ultrastructural study. Int J Surg Pathol. 2002; 10: 281-91
4. Gottlieb C, Raiu U, Greenwald KA. Myoepithelial cells in the differential diagnosis of complex benign and malignant breast lesions: an immunohistochemical study. Mod Pathol 1990; 3:135-40.
5. Man YG, Sang QXA. The significance of focal myoepitehlial cell layer disruptions in breast tumor invasion: a paradigm shift from the "protease-centered" hypothesis. Exp Cell Res 2004;301:103-18
6. Zou Z, Anisowicz A, Hendrix MJ, Thor A, Neveu M, Sheng S, Rafidi K, Seftor E, Sager R. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 1994; 263: 526-29.
7. Barbareschi M, Pecciarini L, Cangi MG, et al. p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast. Am J Surg Pathol 2001; 25:1954-60.
8. Sternlight MD, Barsky SH. The myoepithelial defense: a host defense against cancer. Med Hypotheses 1997; 48:37-46.
9. Li JH, Man YG. Dual usages of single wilms' tumor 1 immunohistochemistry in evaluation of breast tumors. Cancer Biomarkers, in press.
10. Zhang R, Man YG, Vang RS, Saenger JS, Barner R, Wheeler D, Liang CY,Vinh TN, Bratthauer GL. A subset of morphologically distinct mammary myoepithelial cells lacks corresponding immunophenotypic markers. Breast Cancer Res 2003; 5: R151-6
11. Man YG, Tai L, Barner R, Vang R, Saenger JS, Shekitka KM, et al. Cell clusters overlying focally disrupted mammary myoepithelial cell layers and adjacent cells within the same duct display different immunohistochemical and genetic features: implications for tumor progression and invasion. Breast Cancer Res. 2003;5: R231-241
12. Yousefi M, Mattu R, Gao C, Man YG. Mammary ducts with and without focal myoepithelial cell layer disruptions show a different frequency of white blood cell infiltration and growth pattern: Implications for tumor progression and invasion. AIMM. 2005; 13:30-37
13. Man YG, Zhang Y, Shen T, Vinh TN, Zeng X, Tauler J, Mulshine JL, Strauss BL. cDNA expression profiling identifies elevated expressions of tumor progression and invasion related genes in cell clusters of in situ breast tumors. Breast Cancer Res Treat. 2005; 89:199-208
14. Man YG, Shen T, Weisz J, Berg PE, Schwartz AM, Mulshine JL, Sang QXA, Nieburgs HE. A subset of in situ breast tumor cell clusters lacks expression of proliferation and progression related markers but shows signs of stromal and vascular invasion. Cancer Detect Prev. 2005; 29:323-31
15. Man YG, Zhao CQ, Wang J. Breast tumor cell clusters and their budding derivatives show different immunohistochemical profiles during stromal invasion: implications for hormonal and drug therapies. Cancer Therapy. 2006; 4: 193-204
16. Man YG, Nieburgs HE. A subset of cell clusters with malignant features in morphologically normal and hyperplastic breast tissues. Cancer Detect Prev. 2006; 30 (3): 239-47
17. Man YG. Focal degeneration of aged or injured myoepithelial cells and the resultant auto- immunoreactions are trigger factors for breast tumor invasion. Medical Hypotheses.2007; 69(6):1340-57
18. Zhang XC, Hashemi SS, Yousefi M, Gao CL, Sheng J, Mason J, Man YG. Atypical expression of c-erbB2 in cell clusters overlying focally disrupted breast myoepithelial cell layers: a potential sign for increasing cell motility and invasion. Int J Biol Scien. 2008; 4:259-69
19. Man YG. Bad seeds produce bad crops: a single step-process of breast carcinogenesis and Progression. Bioscience Hypotheses. 2008; 1:147-55
20. Mathelin C, Annane K, Treisser A, Chenard MP, Tomasetto C, Bellocq JP, Rio MC. Pregnancy and post-partum breast cancer: a prospective study. Anticancer Res. 2008; 28(4C):2447-52
21. Rodriguez AO, Chew H, Cress R, Xing G, McElvy S, Danielsen B, Smith L. Evidence of poorer survival in pregnancy-associated breast cancer. Obstet Gynecol. 2008; 112(1):71-8
22. Polyak K. Pregnancy and breast cancer: the other side of the coin. Cancer Cell 2006; 9(3):151-3
23. Hu M, Polyak M. Molecular characterization of the tumor microenvironment in breast cancer. Eur J Cancer. 2008 [Epub ahead of print].
24. Tavassoli FA, Man YG. Morphofunctional features of intraductal hyperplasia, atypical hyperplasia, and various grades of intraductal carcinoma. The Breast J. 1995; 1(3):155-62
25. Wagner N, Michiels JF, Schedl A, Wagner KD. The Milms' tumour suppressor WT1 is involved in endothelial cell proliferation and migration:expression in tumo vessels in vivo. Oncogene. 2008; 27: 3662-72
26. Tomkova K, Tomka M, Zajae V. Contribution of p53, p63, and p73 to the developmental diseases and cancer. Neoplasm. 2008; 55(3):177-81
27. Kurita T, Cunha GR, Robboy SJ, Mills AA, Medina RT. Differential expression of p63 in female reproductive organs. Mech Dev. 2005; 122(9):1043-55
28. Scharnhorst V, van der Eb AJ, and Jochemsen AG. WT1proteins: functions in growth and differentiation. Gene. 2001; 273(2): 141-61.
29. Hirose M. The role of Wilms' tumor genes. J Med Invest. 1999; 46(3-4): 130-40
30. Malins DC, Polissar NL, Su Y, Gardner HS, Gunselman SJ. A new structural analysis of DNA using statistical models of infrared sepctra. Nat Med. 1997; 3: 927-30.
31. Malins DC, Johnson PM, Barker EA, et al. Cancer-related changes in prostate DNA as men age and early identification of metastasis in prostate tumors. Proc Natl Acad Sci USA. 2003; 100: 5401-6.
32. Malins DC, Anderson KM, Gilman NK, et al. Development of a cancer DNA phenotype prior to tumor formation. Proc Natl Acad Sci Sci USA. 2004; 101:10721-5.
33. Malins DC, Gilman NK, Green VM, et al. A DNA phenotype in healthy prostates, conserved in tumors and adjacent normal cells, implies a relationship to carcinogenesis. Proc Natl Acad Sci USA. 2005; 102: 19093-6.
34. Barbieri CE, Pietenpol JA. p63 and epithelial biology. Exp Cell Res. 2006; 312(6):695-706
35. Westfall MD, Pietenpol JA. p63: Molecular complexity in development and cancer. Carcinogenesis. 2004; 25(6):857-64
36. Bratthauer GL, Saenger JS, Strauss BL. Antibodies targeting p63 react specifically in the cytoplasm of breast epithelial cells exhibiting secretory differentiation. Histopathology. 2005; 47(6):611-16
37. Liang SH, Clarke MF. Regulation of p53 localization. Eur J Biochem. 2001; 268(10): 2779-83
38. O'Keefe K, Li H, Zhang Y. Nucleocytoplasmic shuttling of p53 is essential for MDM2-mediated cytoplasmic degradation but not ubiquitination. Mol Cell Biol. 2003; 23(18):6396-405
39. Narahashi T, Niki T, Wang T, Goto A, Matsubara D, Funata N, Fukayama M. Cytoplasmic localization of p63 is associated with poor patient survival in lung adenocarcinoma. Histopathology. 2006; 49(4):349-57
40. Rushing EJ, Olsen C, Man YG. Correlation of p63 immunoreactivity with tumor grade in meningiomas. Int J Surg Pathol. 2008; 16(1):38-42
41. Peek RM Jr, Mohla S, DuBois RN. Inflammation in the genesis and perpetuation of cancer: summary and recommendations from a national cancer institute-sponsored meeting. Cancer Res. 2005; 65: 8583-6.
42. MacLennan GT, Eisenberg R, Fleshman RL et al. The influence of chronic inflammation in prostatic carcinogenesis: a 5-year follow-up study. J Urol. 2006; 176: 1012-6.
43. Scharnhorst V, van der Eb AJ, and Jochemsen AG. WT1 proteins: functions in growth and differentiation. Gene. 2001; 273(2):141-61.
44. Re GG, Hazen-Martin DJ, Sens DA, Garvin AJ. Nephroblastoma (Wilms' tumor): a model system of aberrant renal development. Semin Diagn Pathol.1994;11(2):126-35
45. Haber DA, Buckler AJ. WT1: a novel tumor suppressor gene inactivated in Wilms' tumor. New Biol. 1992; 4(2):97-106 46. Armstrong JF, Pritchard-Jones K, Bickmore WA, Hastie ND, Bard JB. The expression of the Wilms' tumor gene, WT1, in the developing mammalian embryo. Mech Dev. 1993; 40(1-2):85-97
46. Scharnhorst V, Menke AL, Attema J, Haneveld JK, Riteco N, van Steenbrugge GL, der Eb AJ, Jochemsen AG. EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorgenicity. Oncogene. 2000; 19(6):791-800
47. Jomgeow T, Oji Y, Tsuji N, Ikeda Y, Ito K, Tsuda A, et al. Wilms' tumor gene WT1 17AA(-)/KTS(-) isoform induces morphological changes and promotes cell migration and invasion in vitro. Cancer Sci. 2006; 97: 259-70
48. Chakravarthy MV, Spangenhurg EE, Booth FW. Culture in low levels of oxygen enhances in vitro proliferation potential of satellite cells from old skeletal muscles. Cell Mol Life Sci. 2001; 58: 1150-58
49. Csete M, Walikonis J, Slawny N, et al. Oxygen-mediated regulation of skeletal muscle satellite cell proliferation and adipogrnesis in culture. J Cell Physical. 2001; 189:189-96
50. Klos KS, Wyszomierski SL, Sun M et al. c-erbB2 increases vascular endothelial growth factor protein synthesis via activation of mammalian target of rapamycin/p70S6K leading to increased angiogenesis and spontaneous metastasis of human breast cancer cells. Cancer Res. 2006; 64: 2028-37
51. Hendrix MJ, Seftor EA, Hess AR, Seftor RE. Vasculogenic mimicry and tumor-cell plasticity: lessons from melanoma. Nat Rev Cancer. 2003; 3(6): 411-21.
52. Kang Y, Massague J. Epithelial-mesenchymal transition: twist in development and metastasis. Cell. 2004; 118: 277-9
53. Sato T, Sakai T, Noguchi Y, Takita M, Hirakawa S, Ito A. Tumor-stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metalloproteinases. Gynecol Oncol. 2004; 92: 47-56